Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV.
Youley TjendraDarcy A KerrYiqin ZuoSilvia Gra MenendezMerce JordaCarmen Gomez-FernandezJaylou M Velez TorresPublished in: Cancer cytopathology (2023)
The MDROM and ROM were trending lower in OFN compared with FN, and the molecular alterations differed between OFN and FN subcategories.